Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease

Infection and Immunity

Volumn 66, Issue 12, 1998, Pages 6022-6023

  Onderdonk, Andrew B ^a,e   Richardson, James A ^b   Hammer, Robert E ^c   Taurog, Joel D ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Simmons Arthritis Research Center   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BACTERIAL COUNT; BACTERIUM ISOLATION; CECUM; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENTERITIS; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC ANIMAL; VERO CELL;

EID: 0031773073     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.12.6022-6023.1998     Document Type: Article

References (12)

1. Breban, M., R. E. Hammer, J. A. Richardson, and J. D. Taurog. 1993. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J. Exp. Med. 178:1606-1616.
2. Dytoc, M., B. Gold, M. Louie, M. Huesca, L. Fedorko, S. Crowe, C. Lingwood, J. Brunton, and P. Sherman. 1993. Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect. Immun. 61:448-456.
3. Elson, C. O., R. B. Sartor, G. S. Tennyson, and R. H. Riddell. 1995. Experimental models of inflammatory bowel disease. Gastroenterology 109:1344-1367.
4. Hammer, R. E., S. D. Maika, J. A. Richardson, J.-P. Tang, and J. D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112.
5. Jerse, A. E. 1991. The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect. Immun. 59:4302-4309.
6. Onderdonk, A. B., J. A. Hermos, and J. G. Bartlett. 1977. The role of the intestinal microflora in experimental colitis. Am. J. Clin. Nutr. 30:1819-1825.
7. Onderdonk, A. B., and J. G. Bartlett. 1979. Bacteriological studies of experimental ulcerative colitis. Am. J. Clin. Nutr. 32:258-265.
8. Rath, H. C., H. H. Herfarth, J. S. Ikeda, W. B. Grenther, T. E. Hamm, Jr., E. Balish, J. D. Taurog, R. E. Hammer, and R. B. Sartor. 1996. Normal luminal bacteria, especially Bacteroides species, mediate chronic colonie, gastric, and systemic inflammation in HLA-B27/hβ2m transgenic rats. J. Clin. Invest. 98:945-953.
9. Simmons, W. A., L. Y. W. Leong, N. Satumtira, G. W. Butcher, J. C. Howard, J. A. Richardson, C. A. Slaughter, R. E. Hammer, and J. D. Taurog. 1996. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. J. Immunol. 156:1661-1667.
10. Taurog, J. D., S. D. Maika, W. A. Simmons, M. Breban, and R. E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168-4178.
11. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, M. Zhou, J. L. Fernandez-Sueiro, E. Balish, and R. E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359-2364.
12. Thayer, W. R., Jr., M. Brown, M. H. Sngree, J. Katz, and T. Hersh. 1969. Escherichia coli O:14 and colon hemaglglutinating antibodies in inflammatory bowel disease. Gastroenterology 57:311-318.